NEWS
News Releases
Abrax Japan Announces License Agreement with the University of Pennsylvania
Dr. Kambayashi wins both competitions in STAT Madness 2022
Abrax Japan announces $3 million Seed 4 financing to support clinical development of ABX-919 for atopic dermatitis
Co-founder of Abrax Japan, Dr. Taku Kambayashi, publishes article in Science entitled “Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion”
read more
LOADING...
Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
Abrax Japan Announces License Agreement with the University of Pennsylvania
Dr. Kambayashi wins both competitions in STAT Madness 2022
Abrax Japan announces $3 million Seed 4 financing to support clinical development of ABX-919 for atopic dermatitis
Co-founder of Abrax Japan, Dr. Taku Kambayashi, publishes article in Science entitled “Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion”
read more
LOADING...